Published literature shows that an increased probability of achieving pCR is correlated with high tumor grade, positive human epidermal growth factor receptor 2 (HER2) status, negative estrogen receptor (ER) status, and triple negative (TN) receptor status [6–9]. This evidence concerns the gene ESR1 and neoplasm.